Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Phoseon’s KeyPro™ family of products uses high-intensity, deep ultraviolet light to disinfect and decontaminate laboratory equipment and surfaces. Independent testing has shown efficacy of KeyPro against viruses, bacteria, fungi, and biomolecules like ribonuclease.

From Phoseon Technology 1 Apr 2020

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Blood donation centers across the U.S. are ramping up efforts to collect plasma from people who have recovered from COVID-19 in hopes it could be used to save the lives of others infected with the pandemic disease.

1 Apr 2020

Total-body PET provides suitable images of antibodies up to 30 days after injection

Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.

31 Mar 2020

Novel, affordable pneumonia vaccine tested in human patients

A novel vaccine against pneumonia that is less expensive and more effective than those currently used in Brazil is being tested in human patients.

31 Mar 2020

New children's book 'Battle Robots of the Blood' released

Immunology expertise has combined with beautifully evocative illustrations to create an engaging book for children and their parents.

31 Mar 2020

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

When a virus invades the body, it leaves fingerprints behind. A research tool known as VirScan can detect this evidence - from just a single drop of blood - and identify the viruses that have infected a person in the past. Soon, the new coronavirus will join the VirScan lineup.

31 Mar 2020

Novel approach to DNA synthesis could help tackle COVID-19 pandemic

Synthetic biology, and particularly DNA synthesis, is transforming diagnosis and treatment of disease, and may yet play a key role in halting the COVID-19 pandemic.

31 Mar 2020

Scientists could soon develop saliva test for measuring cannabis levels in impaired drivers

In the U.S., those who consume alcohol and drive are often subjected to roadside stops, breathalyzer tests and stiff penalties if their blood alcohol content exceeds certain limits.

31 Mar 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020

Monoclonal antibody reduces LDL cholesterol in adult patients with HoFH

The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.

30 Mar 2020

Scientists model human CMV-induced microcephaly using brain organoids

A City of Hope scientist is one step closer to discovering what weakens a pathogen that appears to cause babies to be born with abnormally small heads.

30 Mar 2020

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

30 Mar 2020

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Oncotarget Volume 11, Issue 12 reported outside its natural niche, the cultured prostate cancer stem cells lost their tumor-inducing capability and stem cell marker expression after approximately 8 transfers at a 1:3 split ratio.

27 Mar 2020

Research offers hope for increasing the robustness of vaccine response in older people

Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!

27 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

A promising strategy to overcome drug resistance developed by blood cancer cells

In a collaborative study published in Blood Advances, a research group led by Beate Heissig at Juntendo University and Yousef Salama at An Najah University report a strategy to overcome drug resistance developed by blood cancer cells.

27 Mar 2020

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Today Berkeley Lights, Inc., announced the GEPAD with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples.

From Bruker Cellular Analysis 26 Mar 2020

Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test

Mologic Ltd today announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine.

26 Mar 2020

Antibody News and Research

Further Reading

Putting an end to the pandemic

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Total-body PET provides suitable images of antibodies up to 30 days after injection

Novel, affordable pneumonia vaccine tested in human patients

New children's book 'Battle Robots of the Blood' released

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

Novel approach to DNA synthesis could help tackle COVID-19 pandemic

Scientists could soon develop saliva test for measuring cannabis levels in impaired drivers

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

Monoclonal antibody reduces LDL cholesterol in adult patients with HoFH

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Scientists model human CMV-induced microcephaly using brain organoids

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Research offers hope for increasing the robustness of vaccine response in older people

UC Davis launches two clinical trials to evaluate treatments for COVID-19

A promising strategy to overcome drug resistance developed by blood cancer cells

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test

Antibodies eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo